vs
Side-by-side financial comparison of Arbutus Biopharma Corp (ABUS) and i-80 Gold Corp. (IAUX). Click either name above to swap in a different company.
i-80 Gold Corp. is the larger business by last-quarter revenue ($21.3M vs $10.7M, roughly 2.0× Arbutus Biopharma Corp). Arbutus Biopharma Corp runs the higher net margin — 23.5% vs -401.9%, a 425.4% gap on every dollar of revenue.
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
i-80 Gold Corp is a mineral exploration and development firm focused on gold and silver asset operations in Nevada, US. It advances high-potential mining projects, using responsible extraction practices to deliver precious metals to global industrial and investment markets.
ABUS vs IAUX — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.7M | $21.3M |
| Net Profit | $2.5M | $-85.6M |
| Gross Margin | — | 22.0% |
| Operating Margin | 13.9% | -291.6% |
| Net Margin | 23.5% | -401.9% |
| Revenue YoY | 522.2% | — |
| Net Profit YoY | 112.7% | — |
| EPS (diluted) | $0.01 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $21.3M | ||
| Q3 25 | — | $32.0M | ||
| Q2 25 | $10.7M | $27.8M | ||
| Q1 25 | — | $14.0M | ||
| Q3 24 | — | $11.5M | ||
| Q2 24 | — | $7.2M | ||
| Q4 23 | $2.1M | — | ||
| Q3 23 | $4.7M | — |
| Q4 25 | — | $-85.6M | ||
| Q3 25 | — | $-41.9M | ||
| Q2 25 | $2.5M | $-30.2M | ||
| Q1 25 | — | $-41.2M | ||
| Q3 24 | — | $-43.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q4 23 | — | — | ||
| Q3 23 | $-20.1M | — |
| Q4 25 | — | 22.0% | ||
| Q3 25 | — | 9.7% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | 20.7% | ||
| Q3 24 | — | -42.7% | ||
| Q2 24 | — | -171.4% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q4 25 | — | -291.6% | ||
| Q3 25 | — | -86.7% | ||
| Q2 25 | 13.9% | -67.4% | ||
| Q1 25 | — | -112.3% | ||
| Q3 24 | — | -210.0% | ||
| Q2 24 | — | -435.2% | ||
| Q4 23 | -967.2% | — | ||
| Q3 23 | -462.8% | — |
| Q4 25 | — | -401.9% | ||
| Q3 25 | — | -130.8% | ||
| Q2 25 | 23.5% | -108.5% | ||
| Q1 25 | — | -293.3% | ||
| Q3 24 | — | -374.5% | ||
| Q2 24 | — | -570.8% | ||
| Q4 23 | — | — | ||
| Q3 23 | -431.6% | — |
| Q4 25 | — | $-0.10 | ||
| Q3 25 | — | $-0.05 | ||
| Q2 25 | $0.01 | $-0.05 | ||
| Q1 25 | — | $-0.10 | ||
| Q3 24 | — | $-0.11 | ||
| Q2 24 | — | $-0.11 | ||
| Q4 23 | $-0.12 | — | ||
| Q3 23 | $-0.12 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | $63.2M |
| Total DebtLower is stronger | $0 | $174.7M |
| Stockholders' EquityBook value | $83.0M | $346.8M |
| Total Assets | $103.3M | $703.4M |
| Debt / EquityLower = less leverage | 0.00× | 0.50× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $63.2M | ||
| Q3 25 | — | $102.9M | ||
| Q2 25 | $37.4M | $133.7M | ||
| Q1 25 | — | $13.5M | ||
| Q3 24 | — | $21.8M | ||
| Q2 24 | — | $47.8M | ||
| Q4 23 | $126.0M | — | ||
| Q3 23 | $17.5M | — |
| Q4 25 | — | $174.7M | ||
| Q3 25 | — | $175.9M | ||
| Q2 25 | $0 | $175.8M | ||
| Q1 25 | — | $197.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | $0 | — | ||
| Q3 23 | $0 | — |
| Q4 25 | — | $346.8M | ||
| Q3 25 | — | $423.0M | ||
| Q2 25 | $83.0M | $463.5M | ||
| Q1 25 | — | $318.0M | ||
| Q3 24 | — | $346.9M | ||
| Q2 24 | — | $377.2M | ||
| Q4 23 | $106.0M | — | ||
| Q3 23 | $119.3M | — |
| Q4 25 | — | $703.4M | ||
| Q3 25 | — | $756.2M | ||
| Q2 25 | $103.3M | $782.9M | ||
| Q1 25 | — | $659.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | $144.4M | — | ||
| Q3 23 | $158.6M | — |
| Q4 25 | — | 0.50× | ||
| Q3 25 | — | 0.42× | ||
| Q2 25 | 0.00× | 0.38× | ||
| Q1 25 | — | 0.62× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | 0.00× | — | ||
| Q3 23 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-39.2M |
| FCF MarginFCF / Revenue | — | -184.3% |
| Capex IntensityCapex / Revenue | 0.0% | 23.1% |
| Cash ConversionOCF / Net Profit | -6.24× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-93.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-34.3M | ||
| Q3 25 | — | $-15.2M | ||
| Q2 25 | $-15.7M | $-11.3M | ||
| Q1 25 | — | $-22.7M | ||
| Q3 24 | — | $-23.5M | ||
| Q2 24 | — | $-24.6M | ||
| Q4 23 | $-17.3M | — | ||
| Q3 23 | $-21.8M | — |
| Q4 25 | — | $-39.2M | ||
| Q3 25 | — | $-18.5M | ||
| Q2 25 | — | $-12.4M | ||
| Q1 25 | — | $-23.1M | ||
| Q3 24 | — | $-23.8M | ||
| Q2 24 | — | $-25.1M | ||
| Q4 23 | — | — | ||
| Q3 23 | $-21.8M | — |
| Q4 25 | — | -184.3% | ||
| Q3 25 | — | -57.8% | ||
| Q2 25 | — | -44.7% | ||
| Q1 25 | — | -164.1% | ||
| Q3 24 | — | -206.7% | ||
| Q2 24 | — | -349.1% | ||
| Q4 23 | — | — | ||
| Q3 23 | -468.4% | — |
| Q4 25 | — | 23.1% | ||
| Q3 25 | — | 10.2% | ||
| Q2 25 | 0.0% | 3.9% | ||
| Q1 25 | — | 2.5% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 7.3% | ||
| Q4 23 | 0.0% | — | ||
| Q3 23 | 0.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABUS
Segment breakdown not available.
IAUX
| Granite Creek Mining Company | $20.3M | 95% |
| Ruby Hill Mining Company LLC | $991.0K | 5% |
| Lone Tree Minning Company | $3.0K | 0% |
